TIMI Study Group Takes the Windy City by Storm
Payal Kohli, MD, explains her poster at the ACC Scientific Session in Chicago. |
Faculty and research fellows from the Thrombolysis In Myocardial Infarction (TIMI) Study Group, chaired by Marc Sabatine, MD, MPH, Cardiovascular Division, took Chicago by storm when they presented at this year’s American College of Cardiology’s (ACC's) 61st Annual Scientific Session, which attracted more than 19,000 attendees.
Since its inception in 1984 by Eugene Braunwald, MD, Department of Medicine, the TIMI group has conducted numerous clinical trials in patients with, or at risk for, cardiovascular disease.
“Over the years many of the findings from our TIMI trials have improved our understanding of cardiovascular disease and transformed the care of cardiovascular patients,” said Sabatine. I am very proud that we are off to a tremendous start this year with the presentation of a ground-breaking new TIMI trials, as well as intriguing findings from analyses of several of our previous TIMI trials.”
Jacob Udell, MD, of the Cardiovascular Division, presented his findings that diabetes was associated with a higher risk of cardiovascular problems in men. Christian Ruff, MD, MPH, of the Cardiovascular Division, discussed his study associating DNA length to heart disease risk.
Here are other studies presented by the TIMI group: